Human Papillomavirus Infection and Cervical Cancer Risk Modelling Among Women in Niamey, Niger Republic
Keywords:
Human Papillomavirus, Women, cervical cancer, Niger Republic
Abstract
Background: The impact of human papillomavirus (HPV) infection diagnosis aims to use a cervical cancer screening method in public health programs in West Africa. This study aims to determine the prevalence of HPV infection in women in Niger Republic.
Methods: A prospective cross-sectional study, we randomly selected 598 women, aged 15–75 years, between January 2024 and April 2025 in four healthcare facilities providing gynecological and routine cervical cancer screening in Niamey the capital cities of Niger Republic. We collected informed consent and assent, collected data, and trained participants, to self-collect vaginal or assisted endocervical samples using FloqSwabs. HPV DNA was extracted and amplified using Genotyping Real-time PCR Kit on a Real-time PCR thermocycler (STC-48PLUS). Data were organized using Excel software, and descriptive analyses were performed using IBM SPSS Statistics 29 (IBM Corp., Armonk, NY, USA) and modelling had been performed using R.
Results: The overall prevalence of total HPV and HR-HPV infections in the study population was 12.20% (73/598) and 11.03% (66/598) respectively. HPV infections were confirmed among women from aged group 20–29 years. The commonest HR-HPV types detected were 16 and 66 by followed HPV 35, 53, 31, 45, 52, 68, 58, 26, 51, 59, 18, 33, 39, 73, 82 and 56. The most frequently LR-HPV types were 6 by followed HPV 81 and 11. We also examined factors associated with HPV infection and cervical cancer using multivariate logistic regression models. While no independent predictors of HPV infection were identified, HPV positivity was significantly associated with an increased risk of cervical cancer. Indeed, women who tested positive for HPV had a nearly three times higher risk of diagnosis than women who tested negative.
Conclusion: The prevalence of HPV infection was assessed among women in Niamey, the capital of Niger. Therefore, HPV DNA genotyping and HPV vaccination are necessary for the prevention of cervical cancer in Niger and the rest of West Africa.
Downloads
Download data is not yet available.
References
1. Abdoulaye, O., Alain, Y., B, B.-K. E., F, K. T., D, S. N., K, O. P., Hortense, F.-K., & Mireille, D. (2017). Detection of cervical human papillomavirus in women attending for cervical cancer screening by visual inspection in Cte d Ivoire. Journal of Cancer Research and Experimental Oncology, 9(3), 7‑15. https://doi.org/10.5897/JCREO2017.0152
2. Adams, A. R., Nortey, P. A., Dortey, B. A., Asmah, R. H., & Wiredu, E. K. (2019). Cervical Human Papillomavirus Prevalence, Genotypes, and Associated Risk Factors among Female Sex Workers in Greater Accra, Ghana. Journal of Oncology, 2019(1), 8062176. https://doi.org/10.1155/2019/8062176
3. Adebamowo, C., Rossi, G., & Castle, P. E. (2025). Challenges and Opportunities for Global Cervical Cancer Elimination : How Can We Build a Model for Other Cancers? American Society of Clinical Oncology Educational Book, 45(3), e473702. https://doi.org/10.1200/EDBK-25-473702
4. Adejo, D. S., Aminu, M., Ella, E. E., Oguntayo, O. A., & Obishakin, O. F. (2024). Prevalence of high-risk human papillomavirus genotypes among apparently healthy women with normal and abnormal cervical cytology in Kaduna State, Nigeria. African Journal of Clinical and Experimental Microbiology, 25(1), 17‑27. https://doi.org/10.4314/ajcem.v25i1.3
5. Akarolo-Anthony, S. N., Famooto, A. O., Dareng, E. O., Olaniyan, O. B., Offiong, R., Wheeler, C. M., & Adebamowo, C. A. (2014). Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health, 14, 656. https://doi.org/10.1186/1471-2458-14-656
6. Arbyn, M., Weiderpass, E., Bruni, L., De Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018 : A worldwide analysis. The Lancet Global Health, 8(2), e191‑e203. https://doi.org/10.1016/S2214-109X(19)30482-6
7. Ardhaoui, M., Ennaifer, E., Letaief, H., Salsabil, R., Lassili, T., Chahed, K., Bougatef, S., Bahrini, A., El Fehri, E., Ouerhani, K., Paez Jimenez, A., Guizani, I., Boubaker, M. S., & Ben Alaya, N. B. É. (2016). Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia. PloS One, 11(6), e0157432. https://doi.org/10.1371/journal.pone.0157432
8. Awua, A. K., Sackey, S. T., Osei, Y. D., Asmah, R. H., & Wiredu, E. K. (2016). Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infectious Agents and Cancer, 11(1), 4. https://doi.org/10.1186/s13027-016-0050-4
9. Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., Sy, S., Regan, C., Keane, A., Caruana, M., Nguyen, D. T. N., Smith, M. A., Laprise, J.-F., Jit, M., Alary, M., … Hutubessy, R. (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination : A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England), 395(10224), 575‑590. https://doi.org/10.1016/S0140-6736(20)30068-4
10. Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003). Human papillomavirus types in invasive cervical cancer worldwide : A meta-analysis. British Journal of Cancer, 88(1), 63‑73. https://doi.org/10.1038/sj.bjc.6600688
11. Cosmas, N. T., Nimzing, L., Egah, D., Famooto, A., Adebamowo, S. N., & Adebamowo, C. A. (2022). Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria. BMC Infectious Diseases, 22(1), 340. https://doi.org/10.1186/s12879-022-07215-7
12. Das, S., Doss C, G. P., Fletcher, J., Kannangai, R., Abraham, P., & Ramanathan, G. (2023). The impact of human papilloma virus on human reproductive health and the effect on male infertility : An updated review. Journal of Medical Virology, 95(4), e28697. https://doi.org/10.1002/jmv.28697
13. Emeribe, A. U., Abdullahi, I. N., Etukudo, M. H., Isong, I. K., Emeribe, A. O., Nwofe, J. O., Umeozuru, C. M., Shuaib, B. I., Ajagbe, O. R. O., Dangana, A., Egenti, B. N., & Ghamba, P. E. (2021). The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019 : A systematic review. Annals of Medicine, 53(1), 945‑960. https://doi.org/10.1080/07853890.2021.1938201
14. Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018 : GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941‑1953. https://doi.org/10.1002/ijc.31937
15. García-Gil, A., Luna-Ruiz-Esparza, M. A., Moreno-Camacho, J. L., Calva-Espinosa, D. Y., González-Mena, L. E., Hernández-Lezama, L. F., Kuri-Morales, P., Balcázar-Rodríguez, J. C., Campos-Romero, A., & Alcántar-Fernández, J. (2025). Prevalence of HPV, cytological abnormalities, and impact of the HPV vaccine in Mexico : A Nationwide Study of 596,944 women. The Lancet Regional Health – Americas, 48. https://doi.org/10.1016/j.lana.2025.101156
16. Ginsburg, O., Vanderpuye, V., Beddoe, A. M., Bhoo-Pathy, N., Bray, F., Caduff, C., Florez, N., Fadhil, I., Hammad, N., Heidari, S., Kataria, I., Kumar, S., Liebermann, E., Moodley, J., Mutebi, M., Mukherji, D., Nugent, R., So, W. K. W., Soto-Perez-de-Celis, E., … Soerjomataram, I. (2023). Women, power, and cancer : A Lancet Commission. Lancet (London, England), 402(10417), 2113‑2166. https://doi.org/10.1016/S0140-6736(23)01701-4
17. Grieco, V., Fiorito, D., Giorgianni, G., Irato, E., Prima, A. A. D., Chillari, C., Ippolito, A., Mereu, L., Ragusa, R., Grieco, V., Fiorito, D., Giorgianni, G., Irato, E., Prima, A. A. D., Chillari, C., Ippolito, A., Mereu, L., & Ragusa, R. (2025). HPV Vaccine : An Effective but Underutilized Prevention Tool. International Journal of Environmental Research and Public Health, 22(12). https://doi.org/10.3390/ijerph22121844
18. WHO . (2017). Human papillomavirus vaccines : WHO position paper, May 2017. (s. d.). Consulté 19 janvier 2026, à l’adresse https://www.who.int/publications/i/item/who-wer9219-241-268
19. Iversen, L., Fielding, S., Lidegaard, Ø., & Hannaford, P. C. (2021). Contemporary hormonal contraception and cervical cancer in women of reproductive age. International Journal of Cancer. https://doi.org/10.1002/ijc.33585
20. Jean, Ferlay., M, Ervik., F, Lam., M, Colombet et al. (2018). Cancer Today (powered by GLOBOCAN 2018). Consulté 19 janvier 2026, à l’adresse http://publications.iarc.who.int/Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018--2018
21. Jede, F., Brandt, T., Gedefaw, M., Wubneh, S. B., Abebe, T., Teka, B., Alemu, K., Tilahun, B., Azemeraw, T., Gebeyehu, A., Schmidt, D., Pesic, A., Kaufmann, A. M., Abebe, B., Ayichew, Z., Byczkowski, M., Vaucher, T., Sartor, H., Andargie, G., … Bussmann, H. (2020). Home-based HPV self-sampling assisted by a cloud-based electronic data system : Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia. Papillomavirus Research, 9, 100198. https://doi.org/10.1016/j.pvr.2020.100198
22. Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., Pitisuttithum, P., Restrepo, J. A., Stuart, G., Woelber, L., Yang, Y. C., Cuzick, J., Garland, S. M., Huh, W., Kjaer, S. K., … Broad Spectrum HPV Vaccine Study. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. The New England Journal of Medicine, 372(8), 711‑723. https://doi.org/10.1056/NEJMoa1405044
23. Kabuga, A., Nejati, A., Arero, A., Jalilvand, S., Mokhtari-Azad, T., Sighaldeh, S., Wali, U., & Shahmahmoodi, S. (2020). Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women : A Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention, 21(10), 2837‑2846. https://doi.org/10.31557/APJCP.2020.21.10.2837
24. Kiwerska, K., Jozefiak, A., Markowska, J., Kedzia, W., Jackowska, J., & Wierzbicka, M. (2019). Oral-genital human papillomavirus infection in Polish couples : Frequent detection of HPV 42. BMC Infectious Diseases, 19(1), 122. https://doi.org/10.1186/s12879-018-3645-0
25. Kolawole, O. M., Olatunji, K. T., & Durowade, K. A. (2016). Molecular detection of human papillomavirus from abnormal cervical cytology of women attending a tertiary health facility in Ido-ekiti, southwest Nigeria. Journal of Preventive Medicine and Hygiene, 57(2), E86‑E90.
26. Kombe Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T. (2020). Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Frontiers in Public Health, 8, 552028. https://doi.org/10.3389/fpubh.2020.552028
27. Konaté, A., Sissoko, S. B., Coulibaly, B., Sow, A., Keïta, M., Maïga, R., Traoré, C. B., Kamaté, B., Bayo, S., & Simporé, J. (2019). Génotypage des Virus du Papillome Humain (VPH/HPV) dans les lésions précancéreuses et cancéreuses du col utérin à Bamako (Mali). Mali Santé Publique, 49‑52. https://doi.org/10.53318/msp.v9i01.1478
28. Lessa, A., & Podlasek, A. (2025). Intrauterine devices and gynaecological malignancies—An umbrella review of systematic reviews and meta-analyses. The European Journal of Contraception & Reproductive Health Care: The Official Journal of the European Society of Contraception, 30(4), 177‑189. https://doi.org/10.1080/13625187.2025.2499686
29. Larwanou H, M., Adamou, L., A, Bowon.-Ndandji., Fatimata, H., et al. (2025). Prevalence and genotype distribution of human papillomavirus (HPV) infections among West African populations : A systematic review and meta-analysis. Infectious Agents and Cancer, 20(1). https://doi.org/10.1186/s13027-025-00659-x
30. Li, Z., Liu, P., Yin, A., Zhang, B., Xu, J., Chen, Z., Zhang, Z., Zhang, Y., Wang, S., Tang, L., Kong, B., & Song, K. (2025). Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030 : The urgent need to address inequalities in cervical cancer. International Journal of Cancer, 157(2), 288‑297. https://doi.org/10.1002/ijc.35369
31. Modibbo, F., Iregbu, K. C., Okuma, J., Leeman, A., Kasius, A., De Koning, M., Quint, W., & Adebamowo, C. (2017). Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria. Infectious Agents and Cancer, 12(1), 11. https://doi.org/10.1186/s13027-017-0123-z
32. Muwonga Tukisadila, J., Avala Ntsigouaye, J., Tonen-Wolyec, S., Mboumba Bouassa, R.-S., Muwonga, J., & Belec, L. (2025). Successful Retrieval of Human Papillomavirus DNA in Veil-Based Collected Female Genital Secretions After Long-Term Storage in Universal Transport Medium. Diagnostics, 15(9), 1079. https://doi.org/10.3390/diagnostics15091079
33. OMS . (2020) . Relevé épidémiologique hebdomadaire : Human papillomavirus : WHO po-sition paper, consulté 12/08/2021—Recherche Google. (s. d.). Consulté 19 janvier 2026, à l’adresse https://www.google.com/search?q=OMS+2020.
34. Rodrigues, L. L. S., Morgado, M. G., Sahasrabuddhe, V. V., De Paula, V. S., Oliveira, N. S., Chavez-Juan, E., Da Silva, D. M., Kast, W. M., Nicol, A. F., & Pilotto, J. H. (2018). Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil : High acceptability, hrHPV diversity and risk factors. Gynecologic Oncology, 151(1), 102‑110. https://doi.org/10.1016/j.ygyno.2018.08.004
35. Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., Copeland, G., Cozen, W., Peters, E. S., Huang, Y., Saber, M. S., Altekruse, S., Goodman, M. T., & HPV Typing of Cancers Workgroup. (2015). US assessment of HPV types in cancers : Implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute, 107(6), djv086. https://doi.org/10.1093/jnci/djv086
36. RSU . (2024) . Sociodemographic and general health factor association with high-risk human papilloma virus infection in a prospective study of females residing in Riga, Latvia—RSU. (s. d.). https://science.rsu.lv/en/activities/sociodemographic-and-general-health-factor-association-with-high-/
37. Swanson, M., Ibrahim, S., Blat, C., Oketch, S., Olwanda, E., Maloba, M., & Huchko, M. J. (2018). Evaluating a community-based cervical cancer screening strategy in Western Kenya : A descriptive study. BMC Women’s Health, 18(1), 116. https://doi.org/10.1186/s12905-018-0586-0
38. Tounkara, F. K., Téguété, I., Guédou, F. A., Talbot, D., Traoré, C. B., Béhanzin, L., Traoré, S., Goma-Matsétsé, E., Aza-Gnandji, M., Keita, B., Guenoun, J., Coutlée, F., & Alary, M. (2021). Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 106, 348‑357. https://doi.org/10.1016/j.ijid.2021.04.008
39. Vergara, N., Espinoza, G., Balanda, M., Quiero, A., Hidalgo, W., San Martín, H., Ramírez, A., & Ramírez, E. (2017). Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016. Journal of Medical Virology, 89(9), 1646‑1653. https://doi.org/10.1002/jmv.24805
40. Wei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024). Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide : A systematic analysis of the global literature. Lancet, 404(10451), 435‑444. https://doi.org/10.1016/S0140-6736(24)01097-3
41. Wei, W., Zhang, M., Lin, Y., Li, Z., Luo, W., Zhao, W., Zhuang, J., Zhao, W., Xu, Z., Li, G., Zeng, W., Huang, L., Tan, Y., Yu, Z., & Li, G. (2025). Cohort analysis of high-risk HPV infection in adult women in Dapeng New District, Shenzhen, Guangdong Province, China. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1539209
42. Zohoncon, T. M., Bisseye, C., Djigma, F. W., Yonli, A. T., Compaore, T. R., Sagna, T., Ouermi, D., Ouédraogo, C. M. R., Pietra, V., Nikiéma, J.-B., Akpona, S. A., & Simpore, J. (2013). Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso). Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013059. https://doi.org/10.4084/MJHID.2013.059
2. Adams, A. R., Nortey, P. A., Dortey, B. A., Asmah, R. H., & Wiredu, E. K. (2019). Cervical Human Papillomavirus Prevalence, Genotypes, and Associated Risk Factors among Female Sex Workers in Greater Accra, Ghana. Journal of Oncology, 2019(1), 8062176. https://doi.org/10.1155/2019/8062176
3. Adebamowo, C., Rossi, G., & Castle, P. E. (2025). Challenges and Opportunities for Global Cervical Cancer Elimination : How Can We Build a Model for Other Cancers? American Society of Clinical Oncology Educational Book, 45(3), e473702. https://doi.org/10.1200/EDBK-25-473702
4. Adejo, D. S., Aminu, M., Ella, E. E., Oguntayo, O. A., & Obishakin, O. F. (2024). Prevalence of high-risk human papillomavirus genotypes among apparently healthy women with normal and abnormal cervical cytology in Kaduna State, Nigeria. African Journal of Clinical and Experimental Microbiology, 25(1), 17‑27. https://doi.org/10.4314/ajcem.v25i1.3
5. Akarolo-Anthony, S. N., Famooto, A. O., Dareng, E. O., Olaniyan, O. B., Offiong, R., Wheeler, C. M., & Adebamowo, C. A. (2014). Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health, 14, 656. https://doi.org/10.1186/1471-2458-14-656
6. Arbyn, M., Weiderpass, E., Bruni, L., De Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018 : A worldwide analysis. The Lancet Global Health, 8(2), e191‑e203. https://doi.org/10.1016/S2214-109X(19)30482-6
7. Ardhaoui, M., Ennaifer, E., Letaief, H., Salsabil, R., Lassili, T., Chahed, K., Bougatef, S., Bahrini, A., El Fehri, E., Ouerhani, K., Paez Jimenez, A., Guizani, I., Boubaker, M. S., & Ben Alaya, N. B. É. (2016). Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia. PloS One, 11(6), e0157432. https://doi.org/10.1371/journal.pone.0157432
8. Awua, A. K., Sackey, S. T., Osei, Y. D., Asmah, R. H., & Wiredu, E. K. (2016). Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infectious Agents and Cancer, 11(1), 4. https://doi.org/10.1186/s13027-016-0050-4
9. Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., Sy, S., Regan, C., Keane, A., Caruana, M., Nguyen, D. T. N., Smith, M. A., Laprise, J.-F., Jit, M., Alary, M., … Hutubessy, R. (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination : A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England), 395(10224), 575‑590. https://doi.org/10.1016/S0140-6736(20)30068-4
10. Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003). Human papillomavirus types in invasive cervical cancer worldwide : A meta-analysis. British Journal of Cancer, 88(1), 63‑73. https://doi.org/10.1038/sj.bjc.6600688
11. Cosmas, N. T., Nimzing, L., Egah, D., Famooto, A., Adebamowo, S. N., & Adebamowo, C. A. (2022). Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria. BMC Infectious Diseases, 22(1), 340. https://doi.org/10.1186/s12879-022-07215-7
12. Das, S., Doss C, G. P., Fletcher, J., Kannangai, R., Abraham, P., & Ramanathan, G. (2023). The impact of human papilloma virus on human reproductive health and the effect on male infertility : An updated review. Journal of Medical Virology, 95(4), e28697. https://doi.org/10.1002/jmv.28697
13. Emeribe, A. U., Abdullahi, I. N., Etukudo, M. H., Isong, I. K., Emeribe, A. O., Nwofe, J. O., Umeozuru, C. M., Shuaib, B. I., Ajagbe, O. R. O., Dangana, A., Egenti, B. N., & Ghamba, P. E. (2021). The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019 : A systematic review. Annals of Medicine, 53(1), 945‑960. https://doi.org/10.1080/07853890.2021.1938201
14. Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018 : GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941‑1953. https://doi.org/10.1002/ijc.31937
15. García-Gil, A., Luna-Ruiz-Esparza, M. A., Moreno-Camacho, J. L., Calva-Espinosa, D. Y., González-Mena, L. E., Hernández-Lezama, L. F., Kuri-Morales, P., Balcázar-Rodríguez, J. C., Campos-Romero, A., & Alcántar-Fernández, J. (2025). Prevalence of HPV, cytological abnormalities, and impact of the HPV vaccine in Mexico : A Nationwide Study of 596,944 women. The Lancet Regional Health – Americas, 48. https://doi.org/10.1016/j.lana.2025.101156
16. Ginsburg, O., Vanderpuye, V., Beddoe, A. M., Bhoo-Pathy, N., Bray, F., Caduff, C., Florez, N., Fadhil, I., Hammad, N., Heidari, S., Kataria, I., Kumar, S., Liebermann, E., Moodley, J., Mutebi, M., Mukherji, D., Nugent, R., So, W. K. W., Soto-Perez-de-Celis, E., … Soerjomataram, I. (2023). Women, power, and cancer : A Lancet Commission. Lancet (London, England), 402(10417), 2113‑2166. https://doi.org/10.1016/S0140-6736(23)01701-4
17. Grieco, V., Fiorito, D., Giorgianni, G., Irato, E., Prima, A. A. D., Chillari, C., Ippolito, A., Mereu, L., Ragusa, R., Grieco, V., Fiorito, D., Giorgianni, G., Irato, E., Prima, A. A. D., Chillari, C., Ippolito, A., Mereu, L., & Ragusa, R. (2025). HPV Vaccine : An Effective but Underutilized Prevention Tool. International Journal of Environmental Research and Public Health, 22(12). https://doi.org/10.3390/ijerph22121844
18. WHO . (2017). Human papillomavirus vaccines : WHO position paper, May 2017. (s. d.). Consulté 19 janvier 2026, à l’adresse https://www.who.int/publications/i/item/who-wer9219-241-268
19. Iversen, L., Fielding, S., Lidegaard, Ø., & Hannaford, P. C. (2021). Contemporary hormonal contraception and cervical cancer in women of reproductive age. International Journal of Cancer. https://doi.org/10.1002/ijc.33585
20. Jean, Ferlay., M, Ervik., F, Lam., M, Colombet et al. (2018). Cancer Today (powered by GLOBOCAN 2018). Consulté 19 janvier 2026, à l’adresse http://publications.iarc.who.int/Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018--2018
21. Jede, F., Brandt, T., Gedefaw, M., Wubneh, S. B., Abebe, T., Teka, B., Alemu, K., Tilahun, B., Azemeraw, T., Gebeyehu, A., Schmidt, D., Pesic, A., Kaufmann, A. M., Abebe, B., Ayichew, Z., Byczkowski, M., Vaucher, T., Sartor, H., Andargie, G., … Bussmann, H. (2020). Home-based HPV self-sampling assisted by a cloud-based electronic data system : Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia. Papillomavirus Research, 9, 100198. https://doi.org/10.1016/j.pvr.2020.100198
22. Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., Pitisuttithum, P., Restrepo, J. A., Stuart, G., Woelber, L., Yang, Y. C., Cuzick, J., Garland, S. M., Huh, W., Kjaer, S. K., … Broad Spectrum HPV Vaccine Study. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. The New England Journal of Medicine, 372(8), 711‑723. https://doi.org/10.1056/NEJMoa1405044
23. Kabuga, A., Nejati, A., Arero, A., Jalilvand, S., Mokhtari-Azad, T., Sighaldeh, S., Wali, U., & Shahmahmoodi, S. (2020). Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women : A Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention, 21(10), 2837‑2846. https://doi.org/10.31557/APJCP.2020.21.10.2837
24. Kiwerska, K., Jozefiak, A., Markowska, J., Kedzia, W., Jackowska, J., & Wierzbicka, M. (2019). Oral-genital human papillomavirus infection in Polish couples : Frequent detection of HPV 42. BMC Infectious Diseases, 19(1), 122. https://doi.org/10.1186/s12879-018-3645-0
25. Kolawole, O. M., Olatunji, K. T., & Durowade, K. A. (2016). Molecular detection of human papillomavirus from abnormal cervical cytology of women attending a tertiary health facility in Ido-ekiti, southwest Nigeria. Journal of Preventive Medicine and Hygiene, 57(2), E86‑E90.
26. Kombe Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T. (2020). Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Frontiers in Public Health, 8, 552028. https://doi.org/10.3389/fpubh.2020.552028
27. Konaté, A., Sissoko, S. B., Coulibaly, B., Sow, A., Keïta, M., Maïga, R., Traoré, C. B., Kamaté, B., Bayo, S., & Simporé, J. (2019). Génotypage des Virus du Papillome Humain (VPH/HPV) dans les lésions précancéreuses et cancéreuses du col utérin à Bamako (Mali). Mali Santé Publique, 49‑52. https://doi.org/10.53318/msp.v9i01.1478
28. Lessa, A., & Podlasek, A. (2025). Intrauterine devices and gynaecological malignancies—An umbrella review of systematic reviews and meta-analyses. The European Journal of Contraception & Reproductive Health Care: The Official Journal of the European Society of Contraception, 30(4), 177‑189. https://doi.org/10.1080/13625187.2025.2499686
29. Larwanou H, M., Adamou, L., A, Bowon.-Ndandji., Fatimata, H., et al. (2025). Prevalence and genotype distribution of human papillomavirus (HPV) infections among West African populations : A systematic review and meta-analysis. Infectious Agents and Cancer, 20(1). https://doi.org/10.1186/s13027-025-00659-x
30. Li, Z., Liu, P., Yin, A., Zhang, B., Xu, J., Chen, Z., Zhang, Z., Zhang, Y., Wang, S., Tang, L., Kong, B., & Song, K. (2025). Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030 : The urgent need to address inequalities in cervical cancer. International Journal of Cancer, 157(2), 288‑297. https://doi.org/10.1002/ijc.35369
31. Modibbo, F., Iregbu, K. C., Okuma, J., Leeman, A., Kasius, A., De Koning, M., Quint, W., & Adebamowo, C. (2017). Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria. Infectious Agents and Cancer, 12(1), 11. https://doi.org/10.1186/s13027-017-0123-z
32. Muwonga Tukisadila, J., Avala Ntsigouaye, J., Tonen-Wolyec, S., Mboumba Bouassa, R.-S., Muwonga, J., & Belec, L. (2025). Successful Retrieval of Human Papillomavirus DNA in Veil-Based Collected Female Genital Secretions After Long-Term Storage in Universal Transport Medium. Diagnostics, 15(9), 1079. https://doi.org/10.3390/diagnostics15091079
33. OMS . (2020) . Relevé épidémiologique hebdomadaire : Human papillomavirus : WHO po-sition paper, consulté 12/08/2021—Recherche Google. (s. d.). Consulté 19 janvier 2026, à l’adresse https://www.google.com/search?q=OMS+2020.
34. Rodrigues, L. L. S., Morgado, M. G., Sahasrabuddhe, V. V., De Paula, V. S., Oliveira, N. S., Chavez-Juan, E., Da Silva, D. M., Kast, W. M., Nicol, A. F., & Pilotto, J. H. (2018). Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil : High acceptability, hrHPV diversity and risk factors. Gynecologic Oncology, 151(1), 102‑110. https://doi.org/10.1016/j.ygyno.2018.08.004
35. Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., Copeland, G., Cozen, W., Peters, E. S., Huang, Y., Saber, M. S., Altekruse, S., Goodman, M. T., & HPV Typing of Cancers Workgroup. (2015). US assessment of HPV types in cancers : Implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute, 107(6), djv086. https://doi.org/10.1093/jnci/djv086
36. RSU . (2024) . Sociodemographic and general health factor association with high-risk human papilloma virus infection in a prospective study of females residing in Riga, Latvia—RSU. (s. d.). https://science.rsu.lv/en/activities/sociodemographic-and-general-health-factor-association-with-high-/
37. Swanson, M., Ibrahim, S., Blat, C., Oketch, S., Olwanda, E., Maloba, M., & Huchko, M. J. (2018). Evaluating a community-based cervical cancer screening strategy in Western Kenya : A descriptive study. BMC Women’s Health, 18(1), 116. https://doi.org/10.1186/s12905-018-0586-0
38. Tounkara, F. K., Téguété, I., Guédou, F. A., Talbot, D., Traoré, C. B., Béhanzin, L., Traoré, S., Goma-Matsétsé, E., Aza-Gnandji, M., Keita, B., Guenoun, J., Coutlée, F., & Alary, M. (2021). Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 106, 348‑357. https://doi.org/10.1016/j.ijid.2021.04.008
39. Vergara, N., Espinoza, G., Balanda, M., Quiero, A., Hidalgo, W., San Martín, H., Ramírez, A., & Ramírez, E. (2017). Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016. Journal of Medical Virology, 89(9), 1646‑1653. https://doi.org/10.1002/jmv.24805
40. Wei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024). Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide : A systematic analysis of the global literature. Lancet, 404(10451), 435‑444. https://doi.org/10.1016/S0140-6736(24)01097-3
41. Wei, W., Zhang, M., Lin, Y., Li, Z., Luo, W., Zhao, W., Zhuang, J., Zhao, W., Xu, Z., Li, G., Zeng, W., Huang, L., Tan, Y., Yu, Z., & Li, G. (2025). Cohort analysis of high-risk HPV infection in adult women in Dapeng New District, Shenzhen, Guangdong Province, China. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1539209
42. Zohoncon, T. M., Bisseye, C., Djigma, F. W., Yonli, A. T., Compaore, T. R., Sagna, T., Ouermi, D., Ouédraogo, C. M. R., Pietra, V., Nikiéma, J.-B., Akpona, S. A., & Simpore, J. (2013). Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso). Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013059. https://doi.org/10.4084/MJHID.2013.059
Published
2026-05-16
How to Cite
Harouna Magagi, L., Lagare, A., Hounanrin, W., Issa, M., Hassane, F., Adehossi, E., & Alzouma Maiyaki, Z. (2026). Human Papillomavirus Infection and Cervical Cancer Risk Modelling Among Women in Niamey, Niger Republic. European Scientific Journal, ESJ, 53, 639. Retrieved from https://eujournal.org/index.php/esj/article/view/21023
Section
ESI Preprints
Copyright (c) 2026 Larwanou Harouna Magagi, Adamou Lagare, Wilfried Hounanrin, Moussa Issa, Fatimata Hassane, Eric Adehossi, Zoubeirou Alzouma Maiyaki
This work is licensed under a Creative Commons Attribution 4.0 International License.
